january 1933

Former President Donald Trump faces various legal and political challenges, but few seem to have gotten him as agitated as a routine, expected, unsigned decision by the Supreme Court on Monday.

Trump had already lost a bid to prevent Manhattan District Attorney Cy Vance Jr. from acquiring his financial records via subpoena. The former president then sought a stay while he searched for other means to stall. As anticipated, the justices rejected the request. Trump then issued one of just a handful of public statements he’s issued since leaving office, blasting “the Continuing Political Persecution of President Donald J. Trump.”

His vehemence is part of a long-running pattern: Trump dislikes all investigations, but nothing rattles him like probes into his finances. (When he tried to fire Special Counsel Robert Mueller, it was because of a report that Mueller had subpoenaed his financial records.) We can guess at the reasons. First, Trump is extremely defensive about anything that might imply he is not as rich as he claims. Second, there is much to suggest that Trump might have committed financial crimes.

On its face, reinfection appears to be a straightforward term. It is literally “infection, again”—a recovered person’s second dalliance with the same microbe. Long written into the scientific literature of infectious disease, it is a familiar word, innocuous enough: a microbial echo, an immunological encore act.

But thanks to the pandemic, reinfection has become a semantic and scientific mess.

Newly saddled with the baggage of COVID-19, reinfection has taken on a more terrifying aspect, raising the specter of never-ending cycles of disease. It has sat at the center of debates over testing, immunity, and vaccines; its meaning muddled by ominous headlines, it has become wildly misunderstood. When I ask immunologists about reinfection in the context of the coronavirus, many sigh.

Updated at 10:12 a.m. ET on February 24, 2021.

The end of the coronavirus pandemic is on the horizon at last, but the timeline for actually getting there feels like it shifts daily, with updates about viral variants, vaccine logistics, and other important variables seeming to push back the finish line or scoot it forward. When will we be able to finally live our lives again?

Pandemics are hard to predict accurately, but we have enough information to make some confident guesses. A useful way to think about what’s ahead is to go season by season. In short: Life this spring will not be substantially different from the past year; summer could, miraculously, be close to normal; and next fall and winter could bring either continued improvement or a moderate backslide, followed by a near-certain return to something like pre-pandemic life.

In the middle of January, the deadliest month of the pandemic, one day after inauguration, the Biden administration put out a comprehensive national strategy for “beating COVID-19.” The 200-page document includes many useful goals, such as “Restore trust with the American people” and “Mount a safe, effective, and comprehensive vaccination campaign.” But nowhere does it give a quantitative threshold for when it will be time to say, “Okay, done—we’ve beaten the pandemic.”

A month later, it’s time to get specific. The facts are undeniable: The seven-day average of new cases in the United States has fallen by 74 percent since their January peak, hospitalizations have gone down by 58 percent, and deaths have dropped by 42 percent. Meanwhile, more than 60 million doses of vaccine have gone into American arms. At some point—maybe even some point relatively soon—the remaining emergency measures that were introduced in March 2020 will come to an end. But when, exactly, should that happen?

Updated at 3:33 p.m. ET on February 24, 2021.

Watching Allen v. Farrow, HBO’s new four-part miniseries about the 29-year-old allegations of child molestation against the director Woody Allen, I kept having a feeling that I couldn’t entirely identify. Since revelations about Harvey Weinstein emerged in late 2017—broken, in part, by Allen’s son, Ronan Farrow—harrowing stories about abusive men in the workplace have been reported one after another. But the story of Dylan Farrow, who was 7 years old in 1992, when she told her mother that her father had sexually abused her, is different, an allegation of domestic trauma that’s been weaponized by interested parties again and again. The feeling I had, I eventually realized, was one of wanting to look away. Not because I don’t believe Dylan (I do), or because I believe Allen’s work is so valuable that her testimony is worth shunting aside (I don’t, and no one’s is). It’s queasier than that: a nagging sense that, at this point, there’s still no way for Dylan to tell her story without it being exploited.